CardioComm Solutions, Inc.
TSX VENTURE : EKG

CardioComm Solutions, Inc.

January 29, 2008 09:00 ET

CardioComm Solutions, Inc. Announces Additions to Board of Directors and Management Team

VICTORIA, BRITISH COLUMBIA--(Marketwire - Jan. 29, 2008) - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company") is pleased to announce that Mr. Dirk Hagge, Ph.D., has been added to the board of directors of the Company. Mr. Hagge is an investment banker in Germany with over twenty-five years of practical and oversight experience in both the domestic German and international commercial and investment banking sectors. Mr. Hagge's appointment is subject to the approval of the TSX Venture Exchange.

"We are very pleased to add Mr. Hagge to the board," Brad Harlow, Chairman of the Board, said. "His experience throughout his career as a financial advisor and investment banker, particularly with respect to European and emerging markets, will be a terrific asset for the Company."

In addition, the Company announced that Mr. Etienne Grima, a director of CardioComm, has been appointed as Chief Financial Officer and Corporate Secretary of the Company.

The Company also announced that it has closed its previously announced shares for debt transaction. Under the transaction, $63,450 in debt was settled in exchange for the issuance of an aggregate of 211,499 common shares of the Company to three persons.

About CardioComm Solutions, Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global EKG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions, Inc.

Brad Harlow, Chairman of the Board

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information